![](/img/cover-not-exists.png)
Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies
Romero Prada, ME, Huerfano, LM, Vasquez Melo, EC, Roa Cardenas, NCVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.499
Date:
November, 2016
File:
PDF, 65 KB
english, 2016